{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Comparator&page=55", "query": { "intervention": "Control Comparator", "page": 55 }, "page_size": 10 }, "pagination": { "page": 55, "page_size": 10, "total_count": 1670, "total_pages": 167, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Comparator&page=56&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Comparator&page=54&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T19:16:11.678Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00765336", "title": "A Study to Examine the Effects of Minocycline Extended-Release Tablets on Sperm Production in Human Males.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Human Volunteer" ], "interventions": [ { "name": "minocycline extended release", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Medicis Pharmaceutical Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 180, "start_date": "2006-11", "completion_date": "2009-01", "has_results": true, "last_update_posted_date": "2011-12-07", "last_synced_at": "2026-10-25T19:16:11.678Z", "location_count": 10, "location_summary": "Tarzana, California • Minneapolis, Minnesota • Lawrenceville, New Jersey + 7 more", "locations": [ { "city": "Tarzana", "state": "California" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Lawrenceville", "state": "New Jersey" }, { "city": "Great Neck", "state": "New York" }, { "city": "Purchase", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00765336" }, { "nct_id": "NCT06961006", "title": "A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Malignant Melanoma" ], "interventions": [ { "name": "Intismeran autogene", "type": "BIOLOGICAL" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 160, "start_date": "2025-05-29", "completion_date": "2031-09-05", "has_results": false, "last_update_posted_date": "2026-09-28", "last_synced_at": "2026-10-25T19:16:11.678Z", "location_count": 5, "location_summary": "Springdale, Arkansas • San Francisco, California • Hackensack, New Jersey + 2 more", "locations": [ { "city": "Springdale", "state": "Arkansas" }, { "city": "San Francisco", "state": "California" }, { "city": "Hackensack", "state": "New Jersey" }, { "city": "Fairfax", "state": "Virginia" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT06961006" }, { "nct_id": "NCT00547014", "title": "First Safety Study in Humans of a Single Dose of CPG 52364", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Placebo Comparator: Cohort 1 Placebo", "type": "DRUG" }, { "name": "52364 3 mg", "type": "DRUG" }, { "name": "Placebo Comparator: Cohorts 2, 3, 4 & 5 Two subjects each arm will be assigned to receive placebo", "type": "DRUG" }, { "name": "52364 10 mg", "type": "DRUG" }, { "name": "52364 30 mg", "type": "DRUG" }, { "name": "52364 100 mg", "type": "DRUG" }, { "name": "52364 1 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 61, "start_date": "2007-09", "completion_date": "2008-04", "has_results": false, "last_update_posted_date": "2009-03-19", "last_synced_at": "2026-10-25T19:16:11.678Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00547014" }, { "nct_id": "NCT06645847", "title": "Targeting Aging With a Ketone Ester for Function in Frailty", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Frail Elderly", "Aging", "Immune Function", "Muscle Function" ], "interventions": [ { "name": "Ketone ester", "type": "OTHER" }, { "name": "Placebo Comparator: Non-ketone placebo", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Buck Institute for Research on Aging", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 180, "start_date": "2025-04-17", "completion_date": "2028-04-01", "has_results": false, "last_update_posted_date": "2026-09-09", "last_synced_at": "2026-10-25T19:16:11.678Z", "location_count": 3, "location_summary": "Novato, California • Farmington, Connecticut • Columbus, Ohio", "locations": [ { "city": "Novato", "state": "California" }, { "city": "Farmington", "state": "Connecticut" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06645847" }, { "nct_id": "NCT01392326", "title": "Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Secukinumab (75 mg)", "type": "DRUG" }, { "name": "Secukinumab (150 mg)", "type": "DRUG" }, { "name": "Placebo Comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 606, "start_date": "2011-09", "completion_date": "2014-10", "has_results": true, "last_update_posted_date": "2016-02-04", "last_synced_at": "2026-10-25T19:16:11.678Z", "location_count": 25, "location_summary": "Anniston, Alabama • Mesa, Arizona • Paradise Valley, Arizona + 20 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Paradise Valley", "state": "Arizona" }, { "city": "Upland", "state": "California" }, { "city": "Tamarac", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01392326" }, { "nct_id": "NCT00690443", "title": "Evaluate Safety and Efficacy of AEGR-733 and Atorvastatin vs Atorvastatin Monotherapy in Hypercholesterolemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypercholesterolemia" ], "interventions": [ { "name": "Atorvastatin", "type": "DRUG" }, { "name": "AEGR-733", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aegerion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 44, "start_date": "2008-05", "completion_date": "2008-09", "has_results": true, "last_update_posted_date": "2018-02-23", "last_synced_at": "2026-10-25T19:16:11.678Z", "location_count": 5, "location_summary": "Pinellas Park, Florida • Edina, Minnesota • Mogadore, Ohio + 2 more", "locations": [ { "city": "Pinellas Park", "state": "Florida" }, { "city": "Edina", "state": "Minnesota" }, { "city": "Mogadore", "state": "Ohio" }, { "city": "Dallas", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00690443" }, { "nct_id": "NCT01530763", "title": "Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Infections", "Community Acquired Pneumonia" ], "interventions": [ { "name": "Ceftaroline fosamil", "type": "DRUG" }, { "name": "Ceftriaxone", "type": "DRUG" }, { "name": "amoxicillin clavulanate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": "18 Years", "sex": "ALL", "summary": "2 Months to 18 Years" }, "enrollment_count": 161, "start_date": "2012-09", "completion_date": "2014-07", "has_results": false, "last_update_posted_date": "2015-01-13", "last_synced_at": "2026-10-25T19:16:11.678Z", "location_count": 13, "location_summary": "Long Beach, California • Oakland, California • Orange, California + 10 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01530763" }, { "nct_id": "NCT06744543", "title": "Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Genetic Disease", "Pediatrics", "Predictive Model", "Clinical Decision Support" ], "interventions": [ { "name": "SIGHT Prompted Provider Message", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "20 Years", "sex": "ALL", "summary": "1 Year to 20 Years" }, "enrollment_count": 1000, "start_date": "2025-03-12", "completion_date": "2027-02-01", "has_results": false, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-10-25T19:16:11.678Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT06744543" }, { "nct_id": "NCT02519543", "title": "Treating Insulin Resistance as a Strategy to Improve Outcome in Refractory Bipolar Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Metformin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cynthia Calkin", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2015-09", "completion_date": "2020-09", "has_results": false, "last_update_posted_date": "2021-01-13", "last_synced_at": "2026-10-25T19:16:11.678Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02519543" }, { "nct_id": "NCT07238478", "title": "JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Joint Discomfort", "Joint Pain, Stiffness, Function", "Joint Pain", "Hot Flashes", "Hot Flash", "Night Sweats", "Vasomotor Symptoms" ], "interventions": [ { "name": "JDS-HF3.0", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Bonafide Health", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "50 Years to 70 Years · Female only" }, "enrollment_count": 250, "start_date": "2025-05-14", "completion_date": "2026-10", "has_results": false, "last_update_posted_date": "2025-11-20", "last_synced_at": "2026-10-25T19:16:11.678Z", "location_count": 1, "location_summary": "Harrison, New York", "locations": [ { "city": "Harrison", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07238478" } ] }